AAAAAA

   
Results: 1-15 |
Results: 15

Authors: Zwanzger, P Baghai, TC Schuele, C Strohle, A Padberg, F Kathmann, N Schwarz, M Moller, HJ Rupprecht, R
Citation: P. Zwanzger et al., Vigabatrin decreases cholecystokinin-tetrapeptide (CCK-4) induced panic inhealthy volunteers, NEUROPSYCH, 25(5), 2001, pp. 699-703

Authors: Jahn, H Montkowski, A Knaudt, K Strohle, A Kiefer, F Schick, M Wiedemann, K
Citation: H. Jahn et al., alpha-helical-corticotropin-releasing hormone reverses anxiogenic effects of C-type natriuretic peptide in rats, BRAIN RES, 893(1-2), 2001, pp. 21-28

Authors: Strohle, A Kellner, M Holsboer, F Wiedemann, K
Citation: A. Strohle et al., Anxiolytic activity of atrial natriuretic peptide in patients with panic disorder, AM J PSYCHI, 158(9), 2001, pp. 1514-1516

Authors: Bauer, M Bschor, T Kunz, D Berghofer, A Strohle, A Muller-Oerlinghausen, B
Citation: M. Bauer et al., Lithium discontinuation: Uncovering latent bipolar disorder? Dr. Bauer andcolleagues reply, AM J PSYCHI, 158(8), 2001, pp. 1338-1339

Authors: Strohle, A Holsboer, F Rupprecht, R
Citation: A. Strohle et al., Increased ACTH concentrations associated with cholecystokinin tetrapeptide-induced panic attacks in patients with panic disorder, NEUROPSYCH, 22(3), 2000, pp. 251-256

Authors: Strohle, A
Citation: A. Strohle, Increased response to a putative panicogenic nocebo administration in female patients with panic disorder, J PSYCH RES, 34(6), 2000, pp. 439-442

Authors: Strohle, A Pasini, A Romeo, E Hermann, B Spalletta, G di Michele, F Holsboer, F Rupprecht, R
Citation: A. Strohle et al., Fluoxetine decreases concentrations of 3 alpha,5 alpha-tetrahydrodeoxycorticosterone (THDOC) in major depression, J PSYCH RES, 34(3), 2000, pp. 183-186

Authors: Bauer, M Bschor, T Kunz, D Berghofer, A Strohle, A Muller-Oerlinghausen, B
Citation: M. Bauer et al., Double-blind, placebo-controlled trial of the use of lithium to augment antidepressant medication in continuation treatment of unipolar major depression, AM J PSYCHI, 157(9), 2000, pp. 1429-1435

Authors: Strohle, A Kumpfel, T Sonntag, A
Citation: A. Strohle et al., Paroxetine for depersonalization associated with multiple sclerosis, AM J PSYCHI, 157(1), 2000, pp. 150-150

Authors: Bauer, M Strohle, A
Citation: M. Bauer et A. Strohle, Treatment strategies in refractory bipolar disorder, NERVENARZT, 70(7), 1999, pp. 587

Authors: Rupprecht, R Strohle, A
Citation: R. Rupprecht et A. Strohle, Coincidence of schizophrenia and panic disorder, NERVENARZT, 70(3), 1999, pp. 265-268

Authors: Strohle, A Antonijevic, IA Steiger, A Sonntag, A
Citation: A. Strohle et al., Dependency of non-benzodiazepine hypnotics. Two case reports, NERVENARZT, 70(1), 1999, pp. 72-75

Authors: Strohle, A Kellner, M Holsboer, F Wiedemann, K
Citation: A. Strohle et al., Behavioral, neuroendocrine, and cardiovascular response to flumazenil: No evidence for an altered benzodiazepine receptor sensitivity in panic disorder - Reply, BIOL PSYCHI, 46(12), 1999, pp. 1710-1711

Authors: Strohle, A Romeo, E Hermann, B Pasini, A Spalletta, G di Michele, F Holsboer, F Rupprecht, R
Citation: A. Strohle et al., Concentrations of 3 alpha-reduced neuroactive steroids and their precursors in plasma of patients with major depression and after clinical recovery, BIOL PSYCHI, 45(3), 1999, pp. 274-277

Authors: Strohle, A Kellner, M Holsboer, F Wiedemann, K
Citation: A. Strohle et al., Behavioral, neuroendocrine, and cardiovascular response to flumazenil: No evidence for an altered benzodiazepine receptor sensitivity in panic disorder, BIOL PSYCHI, 45(3), 1999, pp. 321-326
Risultati: 1-15 |